 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | ketamine intranasal spray / CCH Pharma
Journal: Intranasal treatment of cluster headache: A response. (Pubmed Central) - Apr 19, 2022
No abstract available
- || ketamine intranasal spray / CCH Pharma
Clinical, Journal: Intranasal ketamine for acute cluster headache attacks-Results from a proof-of-concept open-label trial. (Pubmed Central) - Feb 22, 2022
Intranasal ketamine may be an effective acute treatment for CH at 30 min but should be tested in a larger controlled design. Patients and physicians should be conscious of the abuse potential of ketamine.
- || ketamine intranasal spray / CCH Pharma
Trial completion: Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache (clinicaltrials.gov) - Feb 24, 2021
P1/2, N=23, Completed, Sponsor: CCH Pharmaceuticals
Patients and physicians should be conscious of the abuse potential of ketamine. Recruiting --> Completed
- | ketamine intranasal spray / CCH Pharma
New P1/2 trial: Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache (clinicaltrials.gov) - Nov 27, 2019
P1/2, N=20, Recruiting, Sponsor: CCH Pharmaceuticals